检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:夏继珍(综述) 刘鑫(审校) 柳英兰(审校)[1] XIA Jizhen;LIU Xin;LIU Yinglan(Department of Gynecology,First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)
机构地区:[1]哈尔滨医科大学附属第一医院妇科三科,哈尔滨150001
出 处:《临床与病理杂志》2022年第1期209-214,共6页Journal of Clinical and Pathological Research
基 金:黑龙江省卫生健康委科研课题(2020-108)。
摘 要:卵巢癌是女性生殖系统中致死率最高的恶性肿瘤,其早期诊断十分困难,尽管手术方式及辅助治疗手段不断在改进,病死率仍居高不下。因此,寻找新的肿瘤标志物和治疗靶点在卵巢癌研究领域方兴未艾。同源盒基因转录反义RNA(homeobox gene transcript antisense intergenic RNA,HOTAIR)是研究最多的长链非编码RNA之一,在卵巢癌中异常表达。作为一类新型的致癌或抑癌因子,可通过多种机制调控肿瘤进展,可作为卵巢癌可靠的新的治疗靶点。Ovarian cancer is the most fatal malignant tumor in the female reproductive system,and its early diagnosis is very difficult.Despite the continuous improvement of surgical methods and adjuvant therapies,the mortality rate remains high.Therefore,the search for new tumor markers and therapeutic targets is in the ascendant in the field of ovarian cancer research.Homeobox gene transcript antisense intergenic RNA(HOTAIR)is one of the most studied long non-coding RNA,which is abnormally expressed in ovarian cancer.As a new type of carcinogenic or inhibitory factor,it can regulate tumor progression through a variety of mechanisms and can be used as a reliable new therapeutic target for ovarian cancer.
关 键 词:长链非编码RNA 同源盒基因转录反义RNA 卵巢上皮性癌
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.69